Supernus Pharmaceuticals, Inc. · NASDAQ:SUPN
Dimensional Fund Advisors LP's stake in Supernus Pharmaceuticals, Inc. fell to 4.70% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 21, 2026
Dimensional Fund Advisors LP's stake in Supernus Pharmaceuticals, Inc. fell to 4.70%, 2,712,341 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G/A).
- Stake
- 4.70%
- Shares
- 2,712,341
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Dimensional Fund Advisors LP | 4.70% | 2,712,341 |